Aurobindo Pharma’s unit recalls Moxifloxacin Ophthalmic Solution in US market

28 Feb 2022 Evaluate

Aurobindo Pharma’s unit -- Aurobindo Pharma USA Inc is recalling 1,15,776 bottles of Moxifloxacin Ophthalmic Solution, an antibiotic used in the treatment of bacterial infections. According to the USFDA, Aurobindo Pharma USA Inc is recalling the affected lot due to ‘failed impurities/degradation specifications’. The company initiated the nationwide Class II recall on January 14 this year.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1140.30 -26.90 (-2.30%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.00
Dr. Reddys Lab 1166.90
Cipla 1377.85
Zydus Lifesciences 872.95
Lupin 2166.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×